Skip to main content
. 2022 Jul 1;12:899335. doi: 10.3389/fonc.2022.899335

Figure 4.

Figure 4

Subgroup analysis of MetS and BCNACT pCR. MetS, metabolic syndrome; pCR, pathologic complete response; RR, risk ratio; CI, confidence interval; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor 2; TNBC, triple negative breast cancer; NACT, neoadjuvant chemotherapy.